Maravai LifeSciences Holdings, Inc. Class Action: The Gross Law Firm Reminds Maravai LifeSciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 5, 2025

Core Viewpoint - Maravai LifeSciences Holdings, Inc. is facing a class action lawsuit due to allegations of misleading statements and inadequate internal controls over financial reporting, particularly regarding revenue recognition and goodwill [3][4]. Summary by Sections Class Period and Allegations - The class period for the lawsuit is from August 7, 2024, to February 24, 2025 [3]. - Allegations include: 1. Lack of adequate internal controls over financial reporting related to revenue recognition 2. Inaccurate revenue recognition on certain transactions during fiscal 2024 3. Overstated goodwill 4. Misleading positive statements about the company's business and prospects [3]. Next Steps for Shareholders - Shareholders are encouraged to register for the class action by May 5, 2025, to participate in potential recovery [4]. - Registration includes enrollment in a portfolio monitoring software for status updates throughout the case lifecycle [4]. Law Firm Information - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors affected by misleading statements [5].